Immunohistochemical expression of Type IV Collagen and Autocrine Motility Factor Receptor in Odontogenic Tumours

Background: Autocrine motility factor receptor (AMFR) is a tumour motility stimulating protein secreted by tumour cells. The protein encoded by this gene is a glycosylated transmembrane protein and a receptor for autocrine motility factor. It has been known to play a role in progression of neopl...

Full description

Bibliographic Details
Main Authors: Harshaminder Kaur Grewal, Sneha Sethi
Format: Article
Language:English
Published: JCDR Research and Publications Private Limited 2014-10-01
Series:Journal of Clinical and Diagnostic Research
Subjects:
Online Access:https://jcdr.net/articles/PDF/4951/9405_CE(Ra)_F(Sh)_PF1(SNAK)_PFA(Sh)_PF2(PAG).pdf
_version_ 1818840662156509184
author Harshaminder Kaur Grewal
Sneha Sethi
author_facet Harshaminder Kaur Grewal
Sneha Sethi
author_sort Harshaminder Kaur Grewal
collection DOAJ
description Background: Autocrine motility factor receptor (AMFR) is a tumour motility stimulating protein secreted by tumour cells. The protein encoded by this gene is a glycosylated transmembrane protein and a receptor for autocrine motility factor. It has been known to play a role in progression of neoplastic lesions. Basement membranes are specialized extracellular matrices that serve as structural barriers as well as substrates for cellular interactions. The network of type IV collagen is thought to define the scaffold integrating other components such as laminins and perlecan into highly organized supramolecular architecture. The aim of this study was to determine and evaluate the immunohistochemical expression of Type IV Collagen and Autocrine motility factor receptor in odontogenic lesions. Materials and Methods: Immunohistochemical expression of Type IV Collagen and Autocrine motility factor receptor was evaluated in 31 odontogenic lesions, including unicystic ameloblastoma, multicystic ameloblastoma, keratocystic odontogenic tumour and ameloblastic carcinoma. Normal follicular tissue formed the control. Results: Maximum expression for Type IV Collagen was seen in multicystic ameloblastoma and minimum expression in keratocystic odontogenic tumour. The maximum expression of AMFR was seen in ameloblastic carcinoma and minimum expression in multicystic ameloblastoma. Conclusion: The results of this study suggested an association of loss of expression of type IV Collagen with progression of lesion. AMFR expression was found to be associated with the aggressive potential of tumours.
first_indexed 2024-12-19T04:13:45Z
format Article
id doaj.art-fc92f06362334959a9a8b890eab5fda9
institution Directory Open Access Journal
issn 2249-782X
0973-709X
language English
last_indexed 2024-12-19T04:13:45Z
publishDate 2014-10-01
publisher JCDR Research and Publications Private Limited
record_format Article
series Journal of Clinical and Diagnostic Research
spelling doaj.art-fc92f06362334959a9a8b890eab5fda92022-12-21T20:36:22ZengJCDR Research and Publications Private LimitedJournal of Clinical and Diagnostic Research2249-782X0973-709X2014-10-01810ZC17ZC2110.7860/JCDR/2014/9405.4951Immunohistochemical expression of Type IV Collagen and Autocrine Motility Factor Receptor in Odontogenic TumoursHarshaminder Kaur Grewal0Sneha Sethi1Professor and Head of Department, Department of Oral Pathology, Seema Dental College and Hospital, Rishikesh, India.Post-Graduate Student, Department of Oral and Maxillofacial Pathology, Maharishi Markandeshwar College of Dental Science and Research, Mullana, Ambala, India.Background: Autocrine motility factor receptor (AMFR) is a tumour motility stimulating protein secreted by tumour cells. The protein encoded by this gene is a glycosylated transmembrane protein and a receptor for autocrine motility factor. It has been known to play a role in progression of neoplastic lesions. Basement membranes are specialized extracellular matrices that serve as structural barriers as well as substrates for cellular interactions. The network of type IV collagen is thought to define the scaffold integrating other components such as laminins and perlecan into highly organized supramolecular architecture. The aim of this study was to determine and evaluate the immunohistochemical expression of Type IV Collagen and Autocrine motility factor receptor in odontogenic lesions. Materials and Methods: Immunohistochemical expression of Type IV Collagen and Autocrine motility factor receptor was evaluated in 31 odontogenic lesions, including unicystic ameloblastoma, multicystic ameloblastoma, keratocystic odontogenic tumour and ameloblastic carcinoma. Normal follicular tissue formed the control. Results: Maximum expression for Type IV Collagen was seen in multicystic ameloblastoma and minimum expression in keratocystic odontogenic tumour. The maximum expression of AMFR was seen in ameloblastic carcinoma and minimum expression in multicystic ameloblastoma. Conclusion: The results of this study suggested an association of loss of expression of type IV Collagen with progression of lesion. AMFR expression was found to be associated with the aggressive potential of tumours.https://jcdr.net/articles/PDF/4951/9405_CE(Ra)_F(Sh)_PF1(SNAK)_PFA(Sh)_PF2(PAG).pdfameloblastomaamfrkeratocystic odontogenic tumourprogression of odontogenic lesionstype iv collagen
spellingShingle Harshaminder Kaur Grewal
Sneha Sethi
Immunohistochemical expression of Type IV Collagen and Autocrine Motility Factor Receptor in Odontogenic Tumours
Journal of Clinical and Diagnostic Research
ameloblastoma
amfr
keratocystic odontogenic tumour
progression of odontogenic lesions
type iv collagen
title Immunohistochemical expression of Type IV Collagen and Autocrine Motility Factor Receptor in Odontogenic Tumours
title_full Immunohistochemical expression of Type IV Collagen and Autocrine Motility Factor Receptor in Odontogenic Tumours
title_fullStr Immunohistochemical expression of Type IV Collagen and Autocrine Motility Factor Receptor in Odontogenic Tumours
title_full_unstemmed Immunohistochemical expression of Type IV Collagen and Autocrine Motility Factor Receptor in Odontogenic Tumours
title_short Immunohistochemical expression of Type IV Collagen and Autocrine Motility Factor Receptor in Odontogenic Tumours
title_sort immunohistochemical expression of type iv collagen and autocrine motility factor receptor in odontogenic tumours
topic ameloblastoma
amfr
keratocystic odontogenic tumour
progression of odontogenic lesions
type iv collagen
url https://jcdr.net/articles/PDF/4951/9405_CE(Ra)_F(Sh)_PF1(SNAK)_PFA(Sh)_PF2(PAG).pdf
work_keys_str_mv AT harshaminderkaurgrewal immunohistochemicalexpressionoftypeivcollagenandautocrinemotilityfactorreceptorinodontogenictumours
AT snehasethi immunohistochemicalexpressionoftypeivcollagenandautocrinemotilityfactorreceptorinodontogenictumours